Skip to main content

Table 3 Charcot foot history

From: Duration of total contact casting for resolution of acute Charcot foot: a retrospective cohort study

 

Median TCC duration

 

Variable

Total

(N = 27)

<  4 months

(n = 12)

>  4 months

(n = 15)

OR (95% CI)

P-value*

Charcot foot

 Left, n (%)

14 (51.9)

4 (33.3)

10 (66.7)

4.00 (0.80 to 20.02)

0.085

 Right, n (%)

13 (48.1)

8 (66.7)

5 (33.3)

0.25 (0.05 to 1.25)

0.085

Stage of Charcot

 Stage 0, n (%)

0 (0)

0 (0)

0 (0)

N/A

N/A

 Stage 1, n (%)

27 (100.0)

12 (100.0)

15 (100.0)

N/A

N/A

Median Charcot duration (IQR), monthsa,b

2.0 (1.0 to 6.0)

2.5 (1.0 to 6.0)

1.8 (0.9 to 6.8)

N/A

0.709†

Charcot trigger

 Ulceration, n (%)

9 (33.3)

5 (41.7)

4 (26.7)

0.51 (0.10 to 2.57)

0.448

 Injury/trauma, n (%)

14 (51.9)

5 (41.7)

9 (60.0)

2.10 (0.45 to 9.84)

0.343

 Amputation, n (%)

2 (7.4)

2 (16.7)

0 (0)

1.20 (0.93 to 1.55)

0.188

 Lymphoedema, n (%)

1 (3.7)

0 (0)

1 (6.7)

0.93 (0.82 to 1.07)

>  0.99

 Unknown, n (%)

1 (3.7)

0 (0)

1 (6.7)

0.93 (0.82 to 1.07)

>  0.99

Charcot misdiagnosis, n (%)

17 (63.0)

7 (58.3)

10 (66.7)

1.43 (0.30 to 6.88)

0.706

Charcot pattern

 Tarsometatarsal joints, n (%)

12 (44.4)

5 (41.7)

7 (46.7)

1.23 (0.27 to 5.67)

0.795

 NC, TN, CC joints, n (%)

11 (40.7)

6 (50.0)

5 (33.3)

0.50 (0.11 to 2.38)

0.452

 Ankle and subtalar joints, n (%)

1 (3.7)

0 (0)

1 (6.7)

0.93 (0.82 to 1.07)

>  0.99

 Combination, n (%)c

3 (11.1)

1 (8.3)

2 (13.3)

1.69 (0.14 to 21.3)

>  0.99

Imaging received

 X-ray, n (%)

27 (100.0)

12 (100.0)

15 (100.0)

N/A

N/A

 Bone scan, n (%)

4 (14.8)

0 (0)

4 (26.7)

0.73 (0.54 to 1.00)

0.106

 MRI, n (%)

4 (14.8)

2 (16.7)

2 (13.3)

0.77 (0.09 to 6.45)

>  0.99

  1. Data are n (%) or OR (95% CI), unless otherwise specified. Percentages may not add up to 100%, as they are rounded to the nearest percent
  2. CC, calcaneocuboid; CI, confidence interval; IQR, interquartile range; MRI, magnetic resonance imaging; N/A, not applicable; NC, naviculocuneiform; OR, odds ratio; SD, standard deviation; TCC, total contact casting; TN, talonavicular
  3. *Significant difference between ‘< 4 months’ and ‘> 4 months’ median TCC duration groups, p < 0.05
  4. aApproximate duration of signs and symptoms consistent with acute Charcot foot prior to attending the high-risk foot service. This information was obtained via patient report within the clinic
  5. bMaximum missing data were for Charcot duration involving 3 participants overall (11.1%)
  6. cTwo participants (7.4%) had a combination Charcot pattern involving the tarsometatarsal joints and the NC, TN and CC joints. One participant (3.7) had a combination Charcot pattern involving the calcaneus and the forefoot
  7. †P-value relates to Mann-Whitney U test